1. Robert J Amato is a Professor and Acting Director of the Division of Oncology at the University of Texas Medical School at Houston and the Chief of the Division of Oncology at Memorial Hermann Cancer Center. His current research focuses on molecular-targeted therapeutics and the further development of immunotherapies.